Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Spring;16(1):45-50.
doi: 10.1111/j.1755-5949.2009.00120.x.

Pregabalin in the treatment of alcohol and benzodiazepines dependence

Panagiotis Oulis  1 , George Konstantakopoulos
Affiliations
Review

Pregabalin in the treatment of alcohol and benzodiazepines dependence

Panagiotis Oulis et al. CNS Neurosci Ther. 2010 Spring.

Abstract

We review all available studies on the use of the newer anticonvulsant drug pregabalin (PGB) in the treatment of both alcohol dependence (AD) and benzodiazepine dependence (BD). In AD, the available evidence includes one open-label and one double-blind randomized studies, whereas in BD, only a few case reports and one open-label study are as yet available. In both conditions, PGB was found efficacious with significant improvement in withdrawal symptoms at the dosage ranges of 150-450 mg/day (AD) and 225-900 mg/day (BD). Moreover, its side effects were mild and transient. Despite the limited quality of the studies design, their findings suggest that PGB might constitute a novel efficacious and safe option in the treatment of both AD and BD.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest with any commercial or other associations in connection with the submitted article.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ben‐Menachem E. Pregabalin pharmacology and its relevance to clinical practice. Epilepsia 2004;45(Suppl 6):13–8. - PubMed
    1. Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Perucca E, Tomson T. Progress report on new antiepileptic drugs: A summary of the Seventh Eilat Conference (EILAT VII). Epilepsy Res 2004;61:1–48. - PubMed
    1. Stahl SM. Mechanism of action of alpha2delta ligands: Voltage sensitive calcium channel (VSCC) modulators. J Clin Psychiatry 2004;65:1033–1034. - PubMed
    1. Kavoussi R. Pregabalin: From molecule to medicine. Eur Neuropsychopharmacol 2006;16(Suppl 2): S128–S133. - PubMed
    1. Dooley DJ, Taylor CP, Donevan S, Feltner D. Ca2+ channel alpha2delta ligands: Novel modulators of neurotransmission. Trends Pharmacol Sci 2007;28:75–82. - PubMed

MeSH terms